CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Net Cash Provided by (Used in) Financing Activities in USD from 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Charles River Laboratories International, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to Q1 2025.
  • Charles River Laboratories International, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 29, 2025 was -$105M, a 674% decline year-over-year.
  • Charles River Laboratories International, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$551M, a 544% decline from 2023.
  • Charles River Laboratories International, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$85.5M, a 102% decline from 2022.
  • Charles River Laboratories International, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$42.4M, a 106% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$105M -$124M -674% Dec 29, 2024 Mar 29, 2025 10-Q 2025-05-07
Q1 2024 $18.3M -$6.9M -27.3% Dec 31, 2023 Mar 30, 2024 10-Q 2025-05-07
Q1 2023 $25.2M +$38.5M Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-09
Q1 2022 -$13.3M -$208M -107% Dec 26, 2021 Mar 26, 2022 10-Q 2023-05-11
Q1 2021 $195M -$284M -59.4% Dec 27, 2020 Mar 27, 2021 10-Q 2022-05-04
Q1 2020 $479M +$548M Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-04
Q1 2019 -$69.1M -$54.1M -363% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-07
Q1 2018 -$14.9M Dec 31, 2017 Mar 31, 2018 10-Q 2019-05-07

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$551M -$465M -544% Dec 31, 2023 Dec 28, 2024 10-K 2025-02-19
2023 -$85.5M -$43.1M -102% Jan 1, 2023 Dec 30, 2023 10-K 2025-02-19
2022 -$42.4M -$715M -106% Dec 26, 2021 Dec 31, 2022 10-K 2025-02-19
2021 $673M +$625M +1324% Dec 27, 2020 Dec 25, 2021 10-K 2024-02-14
2020 $47.2M -$185M -79.6% Dec 29, 2019 Dec 26, 2020 10-K 2023-02-22
2019 $232M -$326M -58.4% Dec 30, 2018 Dec 28, 2019 10-K 2022-02-16
2018 $558M +$767M Dec 31, 2017 Dec 29, 2018 10-K 2021-02-17
2017 -$208M -$589M -155% Jan 1, 2017 Dec 30, 2017 10-K 2020-02-11
2016 $381M Dec 27, 2015 Dec 31, 2016 10-K 2019-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.